barbituric acid has been researched along with Benign Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adibi, H; Eskandari, E; Ghadami, SA; Hosseinzadeh, L; Yarmohammadi, N | 1 |
| Bulte, JW; Chan, KW; Hanes, J; Kinzler, KW; Liu, G; Liu, Q; McMahon, MT; Patel, H; Qiao, Y; van Zijl, PC; Vogelstein, B; Yang, M; Yu, T; Zhou, S | 1 |
2 other study(ies) available for barbituric acid and Benign Neoplasms
| Article | Year |
|---|---|
In vitro evaluation of the anticancer activity of barbituric/thiobarbituric acid-based chromene derivatives.
Topics: Antioxidants; Apoptosis; Barbiturates; Benzopyrans; Caspase 3; Caspase 9; Cell Death; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Screening Assays, Antitumor; Humans; Neoplasms; Reactive Oxygen Species; Structure-Activity Relationship; Thiobarbiturates | 2021 |
A diaCEST MRI approach for monitoring liposomal accumulation in tumors.
Topics: Animals; Antibiotics, Antineoplastic; Barbiturates; Contrast Media; Doxorubicin; Drug Delivery Systems; HEK293 Cells; Hep G2 Cells; Humans; Liposomes; Magnetic Resonance Imaging; Mice; Neoplasms; Optical Imaging; Polyethylene Glycols; Tumor Necrosis Factor-alpha | 2014 |